Soichiro Kakimoto

Soichiro Kakimoto

Auto-generated profile, based on publicly available information

Soichiro Kakimoto

Department of Obstetrics and Gynecology Self‐Defense Force Central Hospital Tokyo Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2020 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
HIHiroki Ishibashi
Hiroki Ishibashi
MMMorikazu Miyamoto
Morikazu Miyamoto
HSHiroshi Shinmoto
Hiroshi Shinmoto
SSShigeyoshi Soga
Shigeyoshi Soga
HMHiroko Matsuura
Hiroko Matsuura
MTMasashi Takano
Masashi Takano

28 May 2020 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
SKSoichiro Kakimoto
Soichiro Kakimoto
MMMorikazu Miyamoto
Morikazu Miyamoto
TETakahiro Einama
Takahiro Einama
HMHiroko Matsuura
Hiroko Matsuura
HIHideki Iwahashi
Hideki Iwahashi
MTMasashi Takano
Masashi Takano

11 April 2020 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
HSHiroaki Soyama
Hiroaki Soyama
MMMorikazu Miyamoto
Morikazu Miyamoto
HMHiroko Matsuura
Hiroko Matsuura
HIHideki Iwahashi
Hideki Iwahashi
SKSoichiro Kakimoto
Soichiro Kakimoto
MTMasashi Takano
Masashi Takano

9 April 2026 in Cancer Reports
Verified
Journal Article
Open access
THTaira Hada
Taira Hada
MMMorikazu Miyamoto
Morikazu Miyamoto
TETakahiro Einama
Takahiro Einama
SKSoichiro Kakimoto
Soichiro Kakimoto
MKMakiko Koga
Makiko Koga
MTMasashi Takano
Masashi Takano
Background: The objective of this study was to establish a new model for predicting the prognosis of endometrial carcinoma (EC) using tumor‐infiltrating lymphocytes (TILs) based on artificial intelligence (AI). Methods: Patients with EC who were treated between 1989 and 2022 were included in this study. For each patient, one hematoxylin and eosin‐stained slide containing the most invasive frontline of the tumor was selected and digitized. The area within a 500 μm width span, extending 250 μm toward the stroma and tumor from the manually annotated invasive frontline, was automatically annotated. The average number of lymphocytes per area (μm 2 ) in the annotated area was calculated using AI. Patients were classified into the High‐TIL and Low‐TIL groups, and survival analysis was conducted. Four mismatch repair (MMR)‐related proteins were evaluated using immunohistochemical staining. Results: A total of 659 patients were included: 346 (52.5%) in the High‐TIL group and 313 (47.5%) in the Low‐TIL group. MMR deficiency was observed more frequently in the High‐TIL group than in the Low‐TIL group ( p < 0.01). Progression‐free survival (PFS) and overall survival (OS) were better in the High‐TIL group than in the Low‐TIL group (both p < 0.01). Multivariate analysis revealed that TIL status was a prognostic factor for PFS (hazard ratio [HR] (95% confidence interval [CI]) 0.61 (0.43–0.87); p < 0.01) and OS (HR (95% CI) 0.54 (0.33–0.86); p = 0.01). Conclusion: TILs evaluated using AI could accurately and significantly predict the prognosis of EC. Further studies are needed to establish new methods for evaluating TILs in ECs.